KLINIK ZONE FOR SUNDHED ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.5% 13.4% 11.1% 13.4% 16.3%  
Credit score (0-100)  22 17 20 16 10  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  135 223 236 280 341  
EBITDA  127 215 228 234 341  
EBIT  127 215 228 234 341  
Pre-tax profit (PTP)  45.2 148.2 177.8 198.7 330.4  
Net earnings  45.2 148.2 174.0 152.5 256.7  
Pre-tax profit without non-rec. items  45.2 148 178 199 330  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 280 280  
Shareholders equity total  -944 -796 -622 -469 -213  
Interest-bearing liabilities  185 0.0 934 698 472  
Balance sheet total (assets)  371 434 393 315 348  

Net Debt  154 -84.2 891 680 421  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  135 223 236 280 341  
Gross profit growth  -28.3% 64.8% 6.0% 18.5% 21.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  371 434 393 315 348  
Balance sheet change%  9.8% 16.9% -9.4% -20.0% 10.5%  
Added value  127.1 214.5 227.9 234.3 340.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 280 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  94.1% 96.4% 96.6% 83.8% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.6% 17.0% 20.3% 26.1% 50.7%  
ROI %  10.7% 19.4% 22.8% 28.7% 58.3%  
ROE %  12.7% 36.8% 42.1% 43.1% 77.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -71.8% -64.7% -63.7% -63.5% -40.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  121.1% -39.2% 391.0% 290.2% 123.4%  
Gearing %  -19.6% 0.0% -150.1% -148.6% -222.0%  
Net interest  0 0 0 0 0  
Financing costs %  41.4% 72.9% 10.7% 4.4% 1.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.3 0.8 0.7 1.3 0.2  
Current Ratio  1.1 2.5 2.1 1.1 0.2  
Cash and cash equivalent  31.6 84.2 42.9 17.8 51.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  31.4 252.8 198.0 17.9 -231.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0